Certified by Founder Lodge
mbiomics GmbH
Germany - Munich, Bavaria
START UP
1 Disclosed Funding Rounds $13,945,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 24 ,2023 | Series A | $13,945,000 |
MIG Capital
Bayern Kapital GmbH
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Revel(US) | $150,000,000 | (Feb 27, 2026)
Bluprynt | $4,250,000 | (Feb 27, 2026)
VITURE | $100,000,000 | (Feb 27, 2026)
ElastixAI | $18,000,000 | (Feb 27, 2026)
UpGuard | $75,000,000 | (Feb 27, 2026)
